ACURASYS
In patients with moderate-severe ARDS does the early use of a neuromuscular blocking agent improve mortality?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
In patients with moderate-severe ARDS does the early use of a neuromuscular blocking agent improve mortality?
Continue reading »In critically ill patients requiring fluid resuscitation, does 6% hydroxyethyl starch (6% HES) compared to 0.9% sodium chloride (Saline) reduce mortality at 90 days?
Continue reading »In patients who are in refractory cardiac arrest, does protocolised management involving mechanical CPR, Hypothermia, ECMO and early reperfusion improve survival rate?
Continue reading »